Evidence map›Paper›PMID 27415438›Full record

ArticlePLoS neglected tropical diseases2016

Integrated Analysis of Environment, Cattle and Human Serological Data: Risks and Mechanisms of Transmission of Rift Valley Fever in Madagascar.

Marie-Marie Olive, Véronique Chevalier, Vladimir Grosbois, Annelise Tran, Soa-Fy Andriamandimby, Benoit Durand, Jean-Pierre Ravalohery, Seta Andriamamonjy, Fanjasoa Rakotomanana, Christophe Rogier and 1 more

Erratum issuedAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Marie-Marie OliveCIRAD, Animal and Integrated Risk Management (AGIRs) Unit, Montpellier, France.
Véronique ChevalierCIRAD, Animal and Integrated Risk Management (AGIRs) Unit, Montpellier, France.
Vladimir GrosboisCIRAD, Animal and Integrated Risk Management (AGIRs) Unit, Montpellier, France.
Annelise TranCIRAD, Animal and Integrated Risk Management (AGIRs) Unit, Montpellier, France.
Soa-Fy AndriamandimbyInstitut Pasteur de Madagascar, Virology Unit, Antananarivo, Madagascar.
Benoit DurandParis-Est University, ANSES, Laboratory for Animal Health, Epidemiology Unit, Maisons-Alfort, France.
Jean-Pierre RavaloheryInstitut Pasteur de Madagascar, Virology Unit, Antananarivo, Madagascar.
Seta AndriamamonjyInstitut Pasteur de Madagascar, Virology Unit, Antananarivo, Madagascar.
Fanjasoa RakotomananaInstitut Pasteur de Madagascar, Epidemiology Unit, Antananarivo, Madagascar.
Christophe RogierInstitut Pasteur de Madagascar, Direction, Antananarivo, Madagascar.
Jean-Michel HeraudInstitut Pasteur de Madagascar, Virology Unit, Antananarivo, Madagascar.

Funding

STRUCTURAL STUDIES IN THE CENTRAL NERVOUS SYSTEMP01AG000001 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 1985 to 2013
$20.7M
PREPAREDNESS AND RESPONSE TO AVIAN AND PANDEMIC INFLUENZA IN MADAGASCARU51IP000327 · IP · PASTEUR INSTITUTE FROM MADAGASCAR · PI HERAUD, JEAN-MICHEL · 2009 to 2012
$1.6M
NCIRD CDC HHS U51 IP000327NIA NIH HHS P01 AG000001
6 · The paper itself

Abstract

backgroundRift Valley fever (RVF) is a vector-borne disease affecting ruminants and humans. Madagascar was heavily affected by RVF in 2008-2009, with evidence of a large and heterogeneous spread of the disease. The identification of at-risk environments is essential to optimize the available resources by targeting RVF surveillance in Madagascar. Herein, the objectives of our study were: (i) to identify the environmental factors and areas favorable to RVF transmission to both cattle and human and (ii) to identify human behaviors favoring human infections in Malagasy contexts. METHODOLOGY/PRINCIPAL

findingsFirst, we characterized the environments of Malagasy communes using a Multiple Factor Analysis (MFA). Then, we analyzed cattle and human serological data collected at national level using Generalized Linear Mixed Models, with the individual serological status (cattle or human) as the response, and MFA factors, as well as other potential risk factors (cattle density, human behavior) as explanatory variables. Cattle and human seroprevalence rates were positively associated to humid environments (p<0.001). Areas with high cattle density were at risk (p<0.01; OR = 2.6). Furthermore, our analysis showed that frequent contact with raw milk contributed to explain human infection (OR = 1.6). Finally, our study highlighted the eastern-coast, western and north-western parts as high-risk areas for RVF transmission in cattle. CONCLUSIONS/SIGNIFICANCE: Our integrated approach analyzing environmental, cattle and human datasets allow us to bring new insight on RVF transmission patterns in Madagascar. The association between cattle seroprevalence, humid environments and high cattle density suggests that concomitant vectorial and direct transmissions are critical to maintain RVF enzootic transmission. Additionally, in the at-risk humid environment of the western, north-western and the eastern-coast areas, suitable to Culex and Anopheles mosquitoes, vectorial transmission probably occurs in both cattle and human. The relative contribution of vectorial or direct transmissions could be further assessed by mathematic modelling.

Indexed as

AdultAnimalsAnophelesAntibodies, ViralCattleCattle DiseasesCross-Sectional StudiesCulexEnvironmentFemaleHumansInsect VectorsMadagascarMaleMiddle AgedRift Valley FeverAntibodies, Viral

Identifiers

PMID27415438
PMCPMC4945045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.